1. Canada Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: major
Cannamerica Brands Corporation

Cannamerica Brands Corporation

OOTC:CNNXF
0.00
USD
0.00
(0.00%)
-0.03EPS
1.30MMarket Cap
2018 Y
2019 Y
2020 Y
2021 Y
TTM
Revenue per Share
- -
0.03
0.02
0.01
0.01
Basic EPS, GAAP
- -
-0.23
-0.09
-0.06
-0.04
Free Cash Flow per Basic Share
- -
-0.03
-0.02
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
Book Value per Share
- -
0.01
-0.06
-0.07
-0.07
Tangible Book Value per Share
- -
-0.04
-0.08
-0.07
-0.07
Basic Weighted Avg Shares
50
39
53
56
67
Sales/Revenue/Turnover
- -
1
1
- -
1
Operating Margin (%)
- -
-495.53
-267.7
-254.81
-131.14
Depreciation Expense
- -
- -
- -
- -
- -
Net Income, GAAP
- -
-9
-5
-4
-3
Effective Tax Rate (%)
- -
- -
- -
- -
- -
Profit Margin (%)
- -
-910.94
-506.03
-918.76
-406.31
Working Capital
- -
-3
-5
-5
-3
LT Debt
- -
- -
- -
- -
- -
Total Equity
- -
1
-3
-5
-5
Return on Invested Capital (%)
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
-2,076.38
- -
- -
- -

Capital Structure

CAD

•

in mil. unless spec.
Jun'22
Sep'22
Dec'22
ST Debt
5
5
2
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
70
70
70
Market Capitalization
3
2
2

Working Capital

CAD

•

in mil. unless spec.
Jun'22
Sep'22
Dec'22
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
5
6
3
Payables & Accruals
- -
- -
- -
ST Debt
5
5
2
Deferred Revenue
- -
1
- -

Growth Rates

CAD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
61.2%
Free Cash Flow
- -
- -
-80.63%
Net Income, GAAP
- -
- -
-23.32%
Sales/Revenue/Turnover
- -
- -
-57.76%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
- -
- -
- -
- -
1
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
-0.02
-0.02
-0.01
-0.04
-0.09
2021
-0.01
- -
-0.02
-0.03
-0.06
2022
- -
- -
-0.01
- -
- -

Quarterly Dividends Per Share

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Christophe Cerisey
Full Time Employees
65
Sector
Health technology
Industry
Pharmaceuticals: major
Address
595 Howe Street Vancouver BC Canada V6C 2T5
IPO Date
Dec 27, 2018
Website
cannamericabrands.com
Similar Companies
Eli Lilly and Company (NYSE:LLY)
Novo Nordisk A/S (NYSE:NVO)
Johnson & Johnson (NYSE:JNJ)
Pfizer, Inc. (NYSE:PFE)
Dr. Reddy's Laboratories Ltd. (NSE:DRREDDY)
Divi's Laboratories Limited (NSE:DIVISLAB)
Business
CannAmerica Brands Corp. (CNNXF) owns and licenses a portfolio of brands offering medical and recreational cannabis products, primarily building and maximizing brand value through promotion, marketing, and licensing via distribution channels including dispensaries, wholesalers, and distributors. The company offers cannabis-infused gummy products, disposable vape pens, distillate droppers, shatter, and wax concentrates under the CannAmerica brand; it previously launched genome-focused and strain-specific edibles in Colorado. Founded in 2017 and headquartered at 595 Howe Street, 10th Floor, Vancouver, British Columbia, Canada V6C 2T5, CannAmerica operates licensing agreements in the states of Colorado, Nevada, Oklahoma, Massachusetts, and Maryland, as well as Canada. Recent developments include resuming distribution in Colorado through licensee Arsenal Oils and Extracts in December 2020 with a new facility for edibles production to fulfill dispensary pre-orders; entering long-term licensing agreements such as with Canna Provisions for Massachusetts distribution in October 2019, Swiss Lux Products for Canada in August 2019, and Total Herbal Care for Oklahoma in July 2019; and launching a CannAmerica Clothing e-commerce division in January 2020 for branded apparel and merchandise. The company targets the specialty cannabis sector within healthcare, serving adult-use and medical consumers through strategic licensees and focusing on U.S. and international market expansion without noted subsidiaries or parent relationships.

Company News

Company News APIChatGPT

  • defenseworld.net

    Ensysce Biosciences (NASDAQ:ENSC) versus CannAmerica Brands (OTCMKTS:CNNXF) Head to Head Review